[HTML][HTML] Helicobacter pylori: management in 2013
YO Alahdab, C Kalayci - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) is a prevalent, worldwide, chronic infection. Choice of
treatment can be modified according to antibiotic-resistance rates of H. pylori. The ideal …
treatment can be modified according to antibiotic-resistance rates of H. pylori. The ideal …
Treatment of Helicobacter pylori
K Wolle, P Malfertheiner - Best Practice & Research Clinical …, 2007 - Elsevier
Triple therapy, consisting of two antibiotics, clarithomycin and amoxicillin or metronidazole in
combination with a proton pump inhibitor (PPI) has become the first-line option for infection …
combination with a proton pump inhibitor (PPI) has become the first-line option for infection …
Optimal therapy for Helicobacter pylori infections
E Rimbara, LA Fischbach, DY Graham - … reviews Gastroenterology & …, 2011 - nature.com
Although Helicobacter pylori infection is both a common and a serious bacterial infection,
antimicrobial therapies have rarely been optimized, are prescribed empirically, and provide …
antimicrobial therapies have rarely been optimized, are prescribed empirically, and provide …
The Optimal First‐Line Therapy of Helicobacter pylori Infection in Year 2012
CH Kuo, FC Kuo, HM Hu, CJ Liu… - Gastroenterology …, 2012 - Wiley Online Library
This paper reviews the literature about first‐line therapies for H. pylori infection in recent
years. First‐line therapies are facing a challenge because of increasing treatment failure …
years. First‐line therapies are facing a challenge because of increasing treatment failure …
[HTML][HTML] Treatment of Helicobacter pylori infection: Current and future insights
Helicobacter pylori (H. pylori) is an important major cause of peptic ulcer disease and gastric
malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric …
malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric …
Treatment of Helicobacter pylori infection: A clinical practice update.
Helicobacter pylori infection still represents a major health issue, especially in developing
countries, with an estimate of 4 billion of infected subjects in 2015. The increase of antibiotic …
countries, with an estimate of 4 billion of infected subjects in 2015. The increase of antibiotic …
[PDF][PDF] REVIEW–TREATMENT OFHELICOBACTER PYLORI INFECTION
V Milivojevic, T Milosavljevic - 2021 - microbiotajournal.com
Helicobacter pylori continues to present therapeutic challenges for clinicians across the
world. This review article aims to consolidate current knowledge of H. pylori infection with a …
world. This review article aims to consolidate current knowledge of H. pylori infection with a …
Treatment of Helicobacter pylori in Special Patient Populations
CT Nguyen, KA Davis, SA Nisly… - … : The Journal of Human …, 2019 - Wiley Online Library
Helicobacter pylori infection can lead to gastritis, gastric and duodenal ulcers, and gastric
cancer. Consequently, complete eradication is the goal of therapy. First‐line therapy for H …
cancer. Consequently, complete eradication is the goal of therapy. First‐line therapy for H …
[HTML][HTML] Treatment of Helicobacter pylori infection: current status and future concepts
JC Yang, CW Lu, CJ Lin - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Helicobacter pylori (H. pylori) infection is highly associated with the occurrence of
gastrointestinal diseases, including gastric inflammation, peptic ulcer, gastric cancer, and …
gastrointestinal diseases, including gastric inflammation, peptic ulcer, gastric cancer, and …
Treatment of Helicobacter pylori infection: A clinical practice update
RM Zagari, S Rabitti, LH Eusebi… - European journal of …, 2018 - Wiley Online Library
Background Helicobacter pylori infection is still frequent in the community and all infected
subjects should be offered an eradication therapy. Nowadays physicians have to face the …
subjects should be offered an eradication therapy. Nowadays physicians have to face the …